Viewing data from:

ENSKYCE

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A201887 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Enskyce (2023)

Total Spending

$92K

Total Claims

3,657

Beneficiaries

904

Avg Cost/Unit

$0.42

Spending Trend

$117K(2019)→$112K(2020)→$107K(2021)→$89K(2022)→$92K(2023)

YoY Change:-4.3%

5yr CAGR:-6.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.15MG;0.03MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 7, 2013

No patent or exclusivity listings for this strength.